Morningside Venture Investments Ltd

Insider Reports History

Entity
Company
Location
Mccarthy Legal Services, 1188 Centre Street, Newton Centre, MA
Signature
/s/ Frances Anne Elizabeth Richard, Director
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Morningside Venture Investments Ltd:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Apellis Pharmaceuticals, Inc. 10%+ Owner Common Stock 12.8M $816M $63.69 Nov 18, 2021 Direct
Amylyx Pharmaceuticals, Inc. 10%+ Owner Common Stock 5M $81.6M $16.33 Aug 15, 2023 Direct
Kezar Life Sciences, Inc. 10%+ Owner Common Stock 1.95M $1.75M $0.90 Aug 15, 2023 Direct
GreenLight Biosciences Holdings, PBC 10%+ Owner Common Stock 0 $0.30 Jul 24, 2023 Direct

Insider Reports Filed by Morningside Venture Investments Ltd

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KZR Kezar Life Sciences, Inc. Aug 15, 2023 1 $0 4 Aug 17, 2023 10%+ Owner
AMLX Amylyx Pharmaceuticals, Inc. Aug 15, 2023 1 $0 4 Aug 17, 2023 10%+ Owner
GRNA GreenLight Biosciences Holdings, PBC Jul 24, 2023 1 $0 4 Jul 25, 2023 10%+ Owner
AMLX Amylyx Pharmaceuticals, Inc. Mar 29, 2023 1 -$885K 4 Mar 31, 2023 10%+ Owner
AMLX Amylyx Pharmaceuticals, Inc. Mar 27, 2023 3 -$4.9M 4 Mar 29, 2023 10%+ Owner
AMLX Amylyx Pharmaceuticals, Inc. Mar 21, 2023 2 -$2.02M 4 Mar 23, 2023 10%+ Owner
AMLX Amylyx Pharmaceuticals, Inc. Mar 16, 2023 1 -$297K 4 Mar 17, 2023 10%+ Owner
AMLX Amylyx Pharmaceuticals, Inc. Mar 14, 2023 3 -$7.43M 4 Mar 16, 2023 10%+ Owner
AMLX Amylyx Pharmaceuticals, Inc. Mar 2, 2023 1 -$1.69M 4 Mar 6, 2023 10%+ Owner
AMLX Amylyx Pharmaceuticals, Inc. Feb 24, 2023 2 -$1.74M 4 Feb 28, 2023 10%+ Owner
AMLX Amylyx Pharmaceuticals, Inc. Feb 22, 2023 4 -$3.58M 4 Feb 24, 2023 10%+ Owner
KZR Kezar Life Sciences, Inc. Feb 3, 2023 2 -$454K 4 Feb 7, 2023 10%+ Owner
KZR Kezar Life Sciences, Inc. Feb 1, 2023 2 -$638K 4 Feb 3, 2023 10%+ Owner
KZR Kezar Life Sciences, Inc. Jan 30, 2023 2 -$420K 4 Feb 1, 2023 10%+ Owner
KZR Kezar Life Sciences, Inc. Jan 25, 2023 1 -$343K 4 Jan 27, 2023 10%+ Owner
KZR Kezar Life Sciences, Inc. Jan 23, 2023 2 -$1.1M 4 Jan 25, 2023 10%+ Owner
KZR Kezar Life Sciences, Inc. Jan 17, 2023 1 -$41.5K 4 Jan 19, 2023 10%+ Owner
KZR Kezar Life Sciences, Inc. Jan 12, 2023 2 -$47.9K 4 Jan 17, 2023 10%+ Owner
KZR Kezar Life Sciences, Inc. Jan 5, 2023 2 -$105K 4 Jan 9, 2023 10%+ Owner
KZR Kezar Life Sciences, Inc. Dec 31, 2022 1 $0 5 Jan 11, 2023 10%+ Owner
AMLX Amylyx Pharmaceuticals, Inc. Dec 31, 2022 4 $0 5 Jan 11, 2023 10%+ Owner
KZR Kezar Life Sciences, Inc. Dec 29, 2022 3 -$396K 4 Jan 5, 2023 10%+ Owner
KZR Kezar Life Sciences, Inc. Oct 3, 2022 2 -$284K 4 Oct 5, 2022 10%+ Owner
GRNA GreenLight Biosciences Holdings, PBC Aug 11, 2022 1 $12M 4 Aug 15, 2022 10%+ Owner
GRNA GreenLight Biosciences Holdings, PBC Feb 2, 2022 0 $0 3 Mar 17, 2022 10%+ Owner
GRNA GreenLight Biosciences Holdings, PBC Feb 2, 2022 4 -$10M 4/A Mar 17, 2022 10%+ Owner
AMLX Amylyx Pharmaceuticals, Inc. Jan 6, 2022 6 $5M 4/A Mar 17, 2022 10%+ Owner
AMLX Amylyx Pharmaceuticals, Inc. Jan 6, 2022 0 $0 3/A Mar 17, 2022 10%+ Owner
APLS Apellis Pharmaceuticals, Inc. Nov 18, 2021 1 $10M 4 Nov 18, 2021 10%+ Owner